재정 지원 요구사항을 통해 공개된 자료 - Robert M. Wilechansky자세히 알아보기
제공된 곳이 있음: 7
Nonalcoholic fatty liver disease and obesity treatment
KT Brunner, CJ Henneberg, RM Wilechansky, MT Long
Current obesity reports 8, 220-228, 2019
재정 지원 요구사항 정책: US National Institutes of Health
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial
TG Simon, RM Wilechansky, S Stoyanova, A Grossman, LE Dichtel, ...
JAMA 331 (11), 920-929, 2024
재정 지원 요구사항 정책: European Commission
Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: a secondary analysis
RM Wilechansky, A Pedley, JM Massaro, U Hoffmann, EJ Benjamin, ...
Liver International 39 (8), 1535-1544, 2019
재정 지원 요구사항 정책: US National Institutes of Health, American Heart Association
The empirical dietary inflammatory pattern score and the risk of nonalcoholic fatty liver disease and cirrhosis
MK Ibrahim, RM Wilechansky, PK Challa, X Zhang, E Giovannucci, ...
Hepatology Communications 7 (10), e0263, 2023
재정 지원 요구사항 정책: US National Institutes of Health
Radiographic hepatic steatosis is not associated with key clinical outcomes among patients hospitalized with COVID-19
HD Trivedi, R Wilechansky, D Goyes, JV Barbosa, A Canakis, M Lai, ...
Gastroenterology Research 14 (3), 179, 2021
재정 지원 요구사항 정책: US National Institutes of Health, Doris Duke Charitable Foundation
time to eat? Skipping breakfast in metabolic‐associated fatty liver disease
RM Wilechansky, TG Simon
Alimentary Pharmacology & Therapeutics 55 (4), 491-493, 2022
재정 지원 요구사항 정책: US National Institutes of Health
Improving the Consent Process With an Informed Consent Video Prior to Outpatient Colonoscopy
EW Lopes, L Boneschansker, JN Chu, JB Ha, YR Badran, PML Diaz, ...
Gastro hep advances 2 (8), 1082-1087, 2023
재정 지원 요구사항 정책: US National Institutes of Health
발행인 및 자금 지원 정보는 컴퓨터 프로그램에서 자동으로 결정됩니다.